RxDoctor Payments Data

Marshal Unrein, PA

Physician Assistant · Fort Morgan, CONPI 1508958612

Payments from drug & device makers

$1,279in general payments, 2019–2025

Across 78 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$285
  • Lilly USA, LLC$178
  • Biohaven Pharmaceutical Holding Company Ltd.$114
  • Merck$106
  • Boehringer Ingelheim$101
  • Biohaven Pharmaceuticals, Inc.$49
  • plus $447 from 17 others

What the payments were for

  • Food & beverage$1,279100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,279 in reported general payments places this provider in the 75th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$120,543
Medicare patients
293
Services billed
7,977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate57$83,721
OzempicSemaglutide26$30,022
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$28,384
XareltoRivaroxaban23$27,508
EliquisApixaban16$21,716
TradjentaLinagliptin13$18,431
JardianceEmpagliflozin18$18,371
Janumet XrSitagliptin Phos/Metformin Hcl16$18,212
Tresiba Flextouch U-200Insulin Degludec11$12,184
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,492
SymbicortBudesonide/Formoterol Fumarate17$5,928
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$5,123
Levothyroxine Sodium281$2,714
Celecoxib19$2,391
Albuterol Sulfate HfaAlbuterol Sulfate41$2,189

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet Xr$106$101,93373 claims
Boehringer IngelheimTradjenta, Jardiance$101$36,80231 claims
Novo NordiskOzempic$285$30,02226 claims
Johnson & JohnsonXarelto$31$27,50823 claims
PfizerEliquis$31$21,71616 claims
AstraZenecaSymbicort$24$5,92817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Fort Morgan

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →